These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7536810)

  • 1. Exacerbation of NMDA, AMPA, and L-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate.
    Greene JG; Greenamyre JT
    J Neurochem; 1995 May; 64(5):2332-8. PubMed ID: 7536810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate.
    Greene JG; Greenamyre JT
    J Neurochem; 1995 Jan; 64(1):430-6. PubMed ID: 7528265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulation of membrane potential modulates malonate-induced striatal excitotoxicity in vivo.
    Greene JG; Greenamyre JT
    J Neurochem; 1996 Feb; 66(2):637-43. PubMed ID: 8592134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for N-methyl-D-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: possible preferential role for N-methyl-D-aspartate receptors.
    Christoffersen CL; Meltzer LT
    Neuroscience; 1995 Jul; 67(2):373-81. PubMed ID: 7545793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
    Willis CL; Meldrum BS; Nunn PB; Anderton BH; Leigh PN
    Brain Res; 1993 Nov; 627(1):55-62. PubMed ID: 7507397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrastriatal injections of the succinate dehydrogenase inhibitor, malonate, cause a rise in extracellular amino acids that is blocked by MK-801.
    Messam CA; Greene JG; Greenamyre JT; Robinson MB
    Brain Res; 1995 Jul; 684(2):221-4. PubMed ID: 7583227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domoic acid neurotoxicity in cultured cerebellar granule neurons is mediated predominantly by NMDA receptors that are activated as a consequence of excitatory amino acid release.
    Berman FW; Murray TF
    J Neurochem; 1997 Aug; 69(2):693-703. PubMed ID: 9231729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum.
    Greene JG; Porter RH; Eller RV; Greenamyre JT
    J Neurochem; 1993 Sep; 61(3):1151-4. PubMed ID: 8360680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of chronic exposure to subthreshold concentrations of quinolinic acid and malonate in the rat striatum.
    Bazzett TJ; Falik RC; Becker JB; Albin RL
    Brain Res; 1996 Apr; 718(1-2):228-32. PubMed ID: 8773793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
    Xue D; Huang ZG; Barnes K; Lesiuk HJ; Smith KE; Buchan AM
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):251-61. PubMed ID: 7509339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of thiopental and propofol on NMDA- and AMPA-mediated glutamate excitotoxicity.
    Zhu H; Cottrell JE; Kass IS
    Anesthesiology; 1997 Oct; 87(4):944-51. PubMed ID: 9357898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of NBQX on the distal and local toxicity of glutamate agonists administered intra-hippocampally.
    Lees GJ; Leong W
    Brain Res; 1993 Nov; 628(1-2):1-7. PubMed ID: 7508807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline protects against both AMPA and kainate-induced lesions in rat striatum in vivo.
    Massieu L; Tapia R
    Neuroscience; 1994 Apr; 59(4):931-8. PubMed ID: 7520137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures.
    Kristensen BW; Noraberg J; Zimmer J
    Brain Res; 2001 Oct; 917(1):21-44. PubMed ID: 11602227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of brain to AMPA induced excitotoxicity transiently peaks during early postnatal development.
    McDonald JW; Trescher WH; Johnston MV
    Brain Res; 1992 Jun; 583(1-2):54-70. PubMed ID: 1380402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of creatine administration against NMDA and malonate toxicity.
    Malcon C; Kaddurah-Daouk R; Beal MF
    Brain Res; 2000 Mar; 860(1-2):195-8. PubMed ID: 10727643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the glutamate receptors mediating release of somatostatin from cultured hippocampal neurons.
    Fontana G; De Bernardi R; Ferro F; Gemignani A; Raiteri M
    J Neurochem; 1996 Jan; 66(1):161-8. PubMed ID: 8522949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons.
    Liljequist S; Cebers G; Kalda A
    Biochem Pharmacol; 1995 Nov; 50(11):1761-74. PubMed ID: 8615854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabotropic and ionotropic excitatory amino acid receptor agonists induce different behavioral effects in mice.
    Laudrup P; Klitgaard H
    Eur J Pharmacol; 1993 Nov; 250(1):15-22. PubMed ID: 7509749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.